Atlantic Healthcare raises $24m from LDC et al.
Cambridge-based gastrointestinal healthcare company Atlantic Healthcare has raised $24m from LDC, as well as existing and new non-institutional sources of capital.
In addition to LDC, the founders of Salix Pharmaceuticals participated, as did the family office Fullbrook Thorpe Investments and existing investors Envestors and the Angel Co-Fund.
The capital injection will support the phase-3 clinical trials of Atlantic's alicaforsen product for the treatment of pouchitis and other inflammatory bowel diseases, as well as filing for regulatory approval of the product in North America and Europe.
The investment is the third round of funding raised by Atlantic Healthcare, having received €1.5m from Envestors and others in November 2010, followed by an undisclosed injection from the Angel Co-Fund in 2013.
Company
Founded in 2006, Atlantic Healthcare is a developer of speciality pharmaceuticals, based in Cambridge.
People
LDC – John Green (investment director).
Atlantic Healthcare – Toby Wilson Waterworth (CEO, founder).
More on Healthcare
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
Czech Republic-headquartered family office is targeting DACH and CEE region deals
CMA scrutiny of high-leverage PE divestment purchases expected to increase
PE could stand to lose its historic advantage with heightened regulatory baggage
Evoco expects portfolio acquisitions, assesses potential exits in 2H23
Switzerland-headquartered GP is currently deploying equity via its EUR 162m Evoco TSE III fund
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater